Shares of Sartorius (OTCPK:SARTF) spiked in European trading on Wednesday after the German life sciences company recorded a strong start to 2025, with its Q1 results sending its U.S. peers higher ...

Sales revenue at 745 million euros, up 10.4 percent in constant currencies 1 (reported: 11.7 percent) Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, started the fiscal ...

Sartorius (0NIR – Research Report) received a Buy rating and a €270.00 price target from Deutsche Bank analyst Falko Friedrichs on April 17. The company’s shares closed last Thursday at € ...

2025 Group EBITDA Margin Guidance: 29% to 30%. 2025 CapEx Ratio Guidance: Around 12.5%. Sartorius AG (SARTF) reported a strong start to 2025 with a 6.5% sales revenue growth in constant currencies.

Guidance for 2025 EBITDA Margin: Expected between 29% to 30%. Sartorius Stedim Biotech SA (SDMHF) reported a strong start to 2025 with a 10% increase in sales revenue for Bioprocess Solutions ...

Sartorius shares rose after the company specified its targets for the year given higher first-quarter earnings and sales that topped analysts' expectations. In European morning trade, shares rose ...

Investing.com -- Sartorius (F:SATG) has been upgraded to “buy” from “hold” by Deutsche Bank, with analyst Falko Friedrichs lowering the price target to €270 from €285. The upgrade ...

Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. At today’s combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A., shareholders granted ...

2025 Group EBITDA Margin Guidance: 29% to 30%. 2025 CapEx Ratio Guidance: Around 12.5%. Sartorius AG (SARTF) reported a strong start to 2025 with a 6.5% sales revenue growth in constant currencies.

University of Glasgow invites scholarships for global students The University of Glasgow has invited applications for its MBA Scholarship 2025, a merit-based financial grant offered by the Adam ...